An initial public offering of 1.3 million shares has been priced by Salt Lake City-based Co-Diagnostics in hopes of obtaining $9 million. The company markets diagnostic equipment for DNA tests.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.